| Name | FC9402 |
|---|
| Description | FC9402 is a potent and selective sulfide quinone oxidoreductase (SQOR) inhibitor extracted from patent WO 2020/146636 A1. FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis. FC9402 can be used for cardiovascular regulation[1]. |
|---|---|
| Related Catalog | |
| Target |
SQOR[1] |
| In Vitro | FC9402 attenuates TAC-induced cardiomyocyte hypertrophy and left ventricle (LV) fibrosis[1]. |
| References |
[1]. WO 2020/146636 A1 |
| Molecular Formula | C19H16N4O |
|---|---|
| Molecular Weight | 316.36 |
| Storage condition | 2-8°C |